Filing Details
- Accession Number:
- 0001181431-14-025055
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-26 15:14:51
- Reporting Period:
- 2014-06-24
- Filing Date:
- 2014-06-26
- Accepted Time:
- 2014-06-26 15:14:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1437402 | Ardelyx Inc. | ARDX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1005561 | J Peter Barris | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No | |
1219855 | James M Barrett | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No | |
1235112 | J Patrick Kerins | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No | |
1237289 | D Scott Sandell | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No | |
1270521 | Kittu Krishna Kolluri | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No | |
1277631 | Forest Baskett | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No | |
1302106 | D Ryan Drant | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No | |
1383389 | Nea 12 Gp, Llc | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No | |
1383390 | Nea Partners 12, Limited Partnership | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No | |
1383391 | New Enterprise Associates 12, Limited Partnership | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-06-24 | 1,415,642 | $0.00 | 1,415,642 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2014-06-24 | 4,404,887 | $0.00 | 5,820,529 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2014-06-24 | 216,573 | $0.00 | 6,037,102 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2014-06-24 | 72,190 | $0.00 | 6,109,292 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2014-06-24 | 510,442 | $14.00 | 6,619,734 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2014-06-24 | 1,415,642 | $0.00 | 1,415,642 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2014-06-24 | 4,404,887 | $0.00 | 4,404,887 | $0.00 |
Series B Preferred Stock | Series B Preferred Stock Purchase Warrant | Disposition | 2014-06-24 | 217,975 | $0.00 | 217,975 | $0.09 |
Common Stock | Series B Preferred Stock | Acquisiton | 2014-06-24 | 217,975 | $0.00 | 217,975 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2014-06-24 | 1,402 | $14.00 | 1,402 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2014-06-24 | 216,573 | $0.00 | 216,573 | $0.00 |
Series B Preferred Stock | Series B Preferred Stock Purchase Warrant | Disposition | 2014-06-24 | 72,658 | $0.00 | 72,658 | $0.09 |
Common Stock | Series B Preferred Stock | Acquisiton | 2014-06-24 | 72,658 | $0.00 | 72,658 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2014-06-24 | 468 | $14.00 | 468 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2014-06-24 | 72,190 | $0.00 | 72,190 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | 2020-11-16 | No | 4 | X | Direct | |
217,975 | No | 4 | X | Direct | ||
216,573 | No | 4 | J | Direct | ||
0 | No | 4 | C | Direct | ||
0 | 2021-04-14 | No | 4 | X | Direct | |
72,658 | No | 4 | X | Direct | ||
72,190 | No | 4 | J | Direct | ||
0 | No | 4 | C | Direct |
Footnotes
- Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into one share of Issuer's Common Stock upon the consummation of the Issuer's initial public offering (the "IPO").
- The shares are directly held by New Enterprise Associates 12, Limited Partnership ("NEA 12") and indirectly held by NEA Partners 12, Limited Partnership ("NEA Partners 12"), the sole general partner of NEA 12, NEA 12 GP, LLC ("NEA 12 GP"), the sole general partner of NEA Partners 12, and the individual managers of NEA 12 GP (NEA Partners 12, NEA 12 GP and the individual managers of NEA 12 GP together, the "NEA 12 Indirect Reporting Persons"). The individual managers of NEA 12 GP are M. James Barrett, Peter J. Barris, Forest Baskett, Ryan D. Drant, Patrick J. Kerins, Krishna "Kittu" Kolluri, and Scott D. Sandell. The NEA 12 Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 12 shares in which the NEA 12 Indirect Reporting Persons have no pecuniary interest.
- The expiration date is not relevant to the conversion of these securities.
- Immediately prior to the closing of the IPO, the warrants automatically net exercised by their terms into Series B Preferred Stock, which allowed the holder to pay the exercise price of the warrants by forfeiting a portion of the exercised warrant shares with a value equal to the aggregate exercise price.
- These shares reflect the net exercise of the preferred stock warrant pursuant to its terms into 216,573 shares of the Issuer's Series B Preferred Stock.
- These shares reflect the net exercise of the preferred stock warrant pursuant to its terms into 72,190 shares of the Issuer's Series B Preferred Stock.